HSRT and IMRT Chemoradiotherapy for Newly Diagnosed GBM

Clinical trial NCT04547621 · UNKNOWN

Trial details

NCT number: NCT04547621
Sponsor: Huashan Hospital
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Glioma, Malignant

Start date: 2020-09-01
Primary completion: 2023-01-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.